BV-MAZOVIA Study
"Effectiveness and safety of consolidative treatment with brentuximab vedotin (BV) in patients with Hodgkin's lymphoma (HL) undergoing autologous stem cell transplantation (ASCT). Prospective, multicenter observational study."
NON-INTERVENTIONAL STUDY
Instruction Contact
Organizer Contact:
BioStat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
(+48) 530 714 118, [email protected]
Contracts and Payments:
Monika Mierzyńska
+48 32 44 027 07,
[email protected]

close
To start entering registration data, please enter the access code and then click the "Register" button.
Access key
FAQ / Polityka Prywatności / Cookies
VV-MEDMAT-51167